SABRINA ESUFALLY JOINS HEMAS BOARD AS EXECUTIVE DIRECTOR

Hemas Holdings PLC has appointed Sabrina Esufally as an Executive Director to its Board, effective 1 July 2026. Bringing commercial leadership and consumer insight, Esufally’s appointment strengthens Hemas’ governance and supports its expansion into frontier markets, aligning with the Group’s long-term strategic ambitions and growth agenda.

Hemas Holdings PLC has announced the appointment of Sabrina Esufally as an Executive Director to its Board, effective 1 July 2026. The move underscores the Group’s commitment to strengthening its leadership team as it continues to expand into frontier markets and pursue long-term strategic ambitions.  

Esufally’s appointment brings a fresh dimension to the Board, combining commercial leadership experience with a strong consumer perspective. Her expertise is expected to complement the collective capabilities of Hemas’ leadership, reinforcing the company’s ability to navigate evolving market dynamics and capture new growth opportunities.  

Hemas Holdings, a diversified conglomerate with interests spanning healthcare, consumer, and mobility sectors, has consistently focused on innovation and expansion. The addition of Esufally to the Board reflects its emphasis on aligning governance with strategic priorities, ensuring that the Group remains agile and responsive to emerging trends across regional and international markets.  

As Hemas positions itself to strengthen its footprint in frontier economies, Esufally’s insights into consumer behaviour and market development are anticipated to play a pivotal role in shaping the Group’s trajectory. Her appointment signals Hemas’ intent to balance operational excellence with forward-looking strategies that resonate with evolving consumer needs.  

The Board’s expansion with Esufally’s inclusion highlights Hemas’ ongoing investment in leadership diversity and expertise, reinforcing its vision of sustainable growth and resilience in an increasingly competitive business landscape.